Dorota Kwapisz

834 total citations
9 papers, 608 citations indexed

About

Dorota Kwapisz is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Dorota Kwapisz has authored 9 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Dorota Kwapisz's work include Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Breast Cancer Treatment Studies (2 papers). Dorota Kwapisz is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), HER2/EGFR in Cancer Research (3 papers) and Breast Cancer Treatment Studies (2 papers). Dorota Kwapisz collaborates with scholars based in Poland. Dorota Kwapisz's co-authors include Joanna Bogusławska and has published in prestigious journals such as Breast Cancer Research and Treatment, Biomedicine & Pharmacotherapy and Cancer Immunology Immunotherapy.

In The Last Decade

Dorota Kwapisz

8 papers receiving 601 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dorota Kwapisz Poland	6	346	302	256	205	57	9	608
Mitsuharu Hirai Japan	15	326 0.9×	219 0.7×	237 0.9×	297 1.4×	45 0.8×	29	690
Anwen Xiong China	13	289 0.8×	231 0.8×	154 0.6×	225 1.1×	56 1.0×	38	559
Anna Truini Italy	18	300 0.9×	337 1.1×	336 1.3×	356 1.7×	48 0.8×	31	731
Christie J. Lau United States	10	264 0.8×	288 1.0×	159 0.6×	148 0.7×	65 1.1×	14	503
Amal Arnaout United States	4	504 1.5×	356 1.2×	232 0.9×	119 0.6×	27 0.5×	4	673
Zahra Asgari United States	9	316 0.9×	113 0.4×	126 0.5×	207 1.0×	49 0.9×	16	537
Nick Beije Netherlands	12	261 0.8×	178 0.6×	383 1.5×	212 1.0×	18 0.3×	25	548
Marco Petronio France	4	407 1.2×	113 0.4×	313 1.2×	166 0.8×	37 0.6×	5	567
Agnese Losurdo Italy	15	371 1.1×	105 0.3×	249 1.0×	231 1.1×	155 2.7×	40	733
Konrad Klinghammer Germany	14	310 0.9×	181 0.6×	125 0.5×	235 1.1×	51 0.9×	53	580

Countries citing papers authored by Dorota Kwapisz

Since Specialization

Citations

This map shows the geographic impact of Dorota Kwapisz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dorota Kwapisz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dorota Kwapisz more than expected).

Fields of papers citing papers by Dorota Kwapisz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dorota Kwapisz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dorota Kwapisz. The network helps show where Dorota Kwapisz may publish in the future.

Co-authorship network of co-authors of Dorota Kwapisz

This figure shows the co-authorship network connecting the top 25 collaborators of Dorota Kwapisz. A scholar is included among the top collaborators of Dorota Kwapisz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dorota Kwapisz. Dorota Kwapisz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kwapisz, Dorota & Joanna Bogusławska. (2023). Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients. Biomedicine & Pharmacotherapy. 163. 114851–114851. 9 indexed citations

2.

Kwapisz, Dorota. (2022). Sacituzumab Govitecan-hziy in Breast Cancer. American Journal of Clinical Oncology. 45(7). 279–285. 4 indexed citations

3.

Kwapisz, Dorota. (2021). Serum free light chains in solid organ transplant recipients. Clinical Transplantation. 35(6). e14286–e14286.

4.

Kwapisz, Dorota. (2020). Pembrolizumab and atezolizumab in triple-negative breast cancer. Cancer Immunology Immunotherapy. 70(3). 607–617. 183 indexed citations

5.

Kwapisz, Dorota. (2018). Cyclin-dependent kinase 4/6 inhibitors in hormone receptor-positive early breast cancer: preliminary results and ongoing studies. Breast Cancer. 25(5). 506–516. 14 indexed citations

6.

Kwapisz, Dorota. (2018). Oligometastatic breast cancer. Breast Cancer. 26(2). 138–146. 29 indexed citations

7.

Kwapisz, Dorota. (2017). Cyclin-dependent kinase 4/6 inhibitors in breast cancer: palbociclib, ribociclib, and abemaciclib. Breast Cancer Research and Treatment. 166(1). 41–54. 158 indexed citations

8.

Kwapisz, Dorota. (2017). The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer?. Annals of Translational Medicine. 5(3). 46–46. 207 indexed citations

9.

Kwapisz, Dorota. (2016). “Signalling pathways in cancer” — a report from the European Society for Medical Oncology symposium. Oncology in Clinical Practice. 12(2). 63–66. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact